Biotechnology Stock on Watch; SLXP – Tech24
By Dr. Matthew Watson
 GuruFocus.com | Biotechnology Stock on Watch; SLXP Tech24 Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) expects the US Food and Drug Administration disapprove the company's bid to widen the uses for its gastrointestinal antibiotic Xifaxan as the regulator needs more information. Xifaxan is currently approved to ... Salix takes center stage in drug-stock tradingMarketWatch |
Uncategorized
Comments Off on Biotechnology Stock on Watch; SLXP – Tech24 |
February 27th, 2011
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research